MTOR and cancer: On the other hand, rapamycin, originally used as an antifungal agent [33], it was later approved as a potential anticancer drug [34], a specific inhibitor of the mammalian target of rapamycin (mTOR) signaling pathway, master regulator of cell growth and metabolism implicated in a number of diseases including diabetes and cancer [35].